Ocean BiomedicalOCEA
13F holders, Q3 2025 (September 30)1holders −5
0new positions
5sold out
$0.00avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Ocean Biomedical Inc. (OCEA) in their 13F filings, down 5 from Q2 2025. 0 opened new positions and 5 sold out. The largest holder was FNY Investment Advisers, LLC ($0).
- Company
- Ocean Biomedical Inc.
- CUSIP
- 67644C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 5 | $6K |
All 13F filers, Q2 2025 → Q3 2025: 811,588 shares sold, net −811,588 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| FNY Investment Advisers, LLC | 0.00% | No change | 600 | $0 |
"% of holder's portfolio" is OCEA's weight in each manager's 13F, not the share of Ocean Biomedical Inc. the manager owns.